Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Combination of Artificial Intelligence and Mucosal Exposure Device to Enhance Colorectal Neoplasia Detection

NCT: NCT05414448 · COMPLETED

NCT IDNCT05414448
StatusCOMPLETED
Start Date2023-03-07
Completion2025-12-31

Brief Summary

The investigators hypothesize that the combined use of CADe system (ENDOAID) and mucosal exposure device (Endocuff Vision®) would improve the adenoma detection rate when compared to CADe system alone.

Frequently Asked Questions

What is Combination of Artificial Intelligence and Mucosal Exposure Device to Enhance Colorectal Neoplasia Detection?

Combination of Artificial Intelligence and Mucosal Exposure Device to Enhance Colorectal Neoplasia Detection is a clinical trial registered under NCT05414448. Current status: COMPLETED.

What is the status of NCT05414448?

The current status of NCT05414448 (Combination of Artificial Intelligence and Mucosal Exposure Device to Enhance Colorectal Neoplasia Detection) is: COMPLETED.

When did Combination of Artificial Intelligence and Mucosal Exposure Device to Enhance Colorectal Neoplasia Detection start?

Combination of Artificial Intelligence and Mucosal Exposure Device to Enhance Colorectal Neoplasia Detection started on 2023-03-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑